The purpose of the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE is to provide intellectual and physical resources (particularly state-of-the-art mass spectrometry analysis of sphingolipids and synthetic molecular tools to study importance of lipids) to enhance our understanding of the role of bioactive lipids in different diseases with the goal to discover future drugs. Core services include: 1) Providing synthetic molecular tools to study lipid metabolism (e.g., functionalized and fluorescent ceramides, site-specific radioactive sphingolipids) and diversified synthetic lipids and analogs for cellular, in vitro, and in vivo studies (e.g., organelle-targeted sphingolipids and organelle-targeted inhibitors of sphingolipid metabolizing enzymes). 2) Providing qualitative and quantitative analysis of lipid components from different biological materials (cells, tissue, and biological fluids), employing high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) technology. The core currently provides quantitative analysis of more than 200 distinct lipid molecular species. 3) Providing conceptual and practical training in various aspects of lipidology. The core also assists COBRE investigators in experimental design, selection of lipids of interest, and interpretation of analytical results. The Lipidomics Core of the Center for Lipidomics and Pathobiology at the Medical University of South Carolina (MUSC) is a novel scientific resource that provides synthetic and analytical services to biomedical investigators at MUSC. Owing to the unique nature of the services, collaborative investigators at research institutions around the world, as well as some pharma/biotech concerns, also have come to rely on this outstanding core resource. The COBRE Phase III transition for this Core builds upon previous investments of the NCRR COBRE Phase I and II programs, NCRR Shared Instrumentation Grants, NCI Program Project Grant Phase I and II programs, and NCI Cancer Center Support Grant program. This unique and very successful COBRE Core has developed into an institutional, national, and international resource.
This proposal is to support several unique core resources that significantly enhance research on novel bioactive lipids that are involved in many important diseases including cancer, neurodegeneration, diabetes and cardiovascular disease. Moreover the research has significant impact on drug discovery and innovative biomedical industry that will benefit the economy of SC.
|Panneer Selvam, Shanmugam; Roth, Braden M; Nganga, Rose et al. (2018) Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3. J Biol Chem 293:9784-9800|
|Fekry, Baharan; Jeffries, Kristen A; Esmaeilniakooshkghazi, Amin et al. (2018) C16-ceramide is a natural regulatory ligand of p53 in cellular stress response. Nat Commun 9:4149|
|Kim, Myung Jong; Jeon, Sohee; Burbulla, Lena F et al. (2018) Acid ceramidase inhibition ameliorates ?-synuclein accumulation upon loss of GBA1 function. Hum Mol Genet 27:1972-1988|
|Helke, Kristi; Angel, Peggi; Lu, Ping et al. (2018) Ceramide Synthase 6 Deficiency Enhances Inflammation in the DSS model of Colitis. Sci Rep 8:1627|
|Scheffel, Matthew J; Helke, Kristi; Lu, Ping et al. (2017) Adoptive Transfer of Ceramide Synthase 6 Deficient Splenocytes Reduces the Development of Colitis. Sci Rep 7:15552|
|Ghatak, Shibnath; Markwald, Roger R; Hascall, Vincent C et al. (2017) Transforming growth factor ?1 (TGF?1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts. J Biol Chem 292:10465-10489|
|Ghatak, Shibnath; Hascall, Vincent C; Markwald, Roger R et al. (2017) Transforming growth factor ?1 (TGF?1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis. J Biol Chem 292:10490-10519|
|Gencer, Salih; Oleinik, Natalia; Kim, Jisun et al. (2017) TGF-? receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis. Sci Signal 10:|
|Bai, Aiping; Mao, Cungui; Jenkins, Russell W et al. (2017) Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase. PLoS One 12:e0177805|
|Kim, Soohyun P; Frey, Julie L; Li, Zhu et al. (2017) Lack of Lrp5 Signaling in Osteoblasts Sensitizes Male Mice to Diet-Induced Disturbances in Glucose Metabolism. Endocrinology 158:3805-3816|
Showing the most recent 10 out of 21 publications